Sg3 Management, LLC Soleno Therapeutics Inc Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

A detailed history of Sg3 Management, LLC transactions in Soleno Therapeutics Inc stock. As of the latest transaction made, Sg3 Management, LLC holds 233,000 shares of SLNO stock, worth $13 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
233,000
Holding current value
$13 Million
% of portfolio
0.04%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $451M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email